Full Text View
Tabular View
No Study Results Posted
Related Studies
Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
This study has been completed.
Study NCT00141323   Information provided by Ligand Pharmaceuticals

First Received on August 30, 2005.   Last Updated on August 8, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoporosis
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Musculoskeletal Diseases
Interventions listed in this trial
lasofoxifene
placebo
Sponsors listed in this trial
Ligand Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services